Tom Hancock, portfolio manager at GMO, offers a distinct view on "quality" investing that combines a high-tech concentration with deep value in overlooked sectors like healthcare, steering clear of traditional sector diversification.
Core Philosophy: Quality at a Reasonable Price
- Definition: Seeks companies with high, sustainable returns on capital that can reinvest in growth, but avoids those trading at "superhigh multiples."
- Market View: Contrary to GMO's bearish reputation, Hancock is not bearish on current U.S. market valuations. He argues the market's higher overall P/E ratio reflects a greater proportion of genuinely high-quality growth stocks, not a bubble.
Key Portfolio Strategies and Holdings
Hancock's strategy is defined by concentrated, high-conviction bets in two main areas:
| Investment Focus | Rationale & Stock Examples | Key Characteristic |
|---|---|---|
| High-Conviction Tech (41% of fund) | Focus on "safer" AI plays with diversified revenue and strong balance sheets. | Defensive within Tech |
| Examples: Microsoft, Broadcom, Lam Research | Favors companies with proven customer monetization (e.g., Broadcom's custom chips for hyperscalers). Sold Oracle due to debt risk linked to OpenAI deal. | |
| Contrarian Value: Healthcare & Staples | Sees sustainable long-term tailwinds (aging population, innovation) outweighing short-term disruptions (Medicaid eligibility changes). | Exploiting Short-Term Weakness |
| Examples: UnitedHealth, Eli Lilly, Merck, Coca-Cola | Views patent expirations in pharma as overstated risks for companies with proven R&D/commercialization pipelines (e.g., Merck at ~11x forward earnings). |
Notable Omissions: The fund holds no positions in basic materials, real estate, energy, or utilities, as Hancock believes outperformance requires a concentrated portfolio in chosen "baskets."
Performance & Risk Management
- Track Record: Hancock's GMO Quality III mutual fund returned 15.6% annually over the past decade, outperforming the S&P 500 (14.4%).
- AI Crash Outlook: Acknowledges a significant downturn in AI stocks is likely but prefers to own "defensive" tech names (like Microsoft) that can survive a pullback, rather than risk missing upside.
- Consumer Bets: Holds contrarian positions in consumer staples, favoring Coca-Cola over PepsiCo and seeing recent weakness in alcohol (e.g., Constellation Brands) as cyclical, not structural.
💎 Conclusion
Hancock's strategy demonstrates that "quality" investing need not be defensive or benchmark-hugging. It can be a high-conviction, concentrated approach that aggressively tilts toward reasonably-priced tech leaders while simultaneously digging for deep value in out-of-favor sectors like healthcare. The success hinges on strict adherence to financial durability and avoiding overpaying, even for growth.